The subjects enrolled for clinical trial were allocated to
either one of the treatment groups viz., placebo, NR-INF-
02, GS, combination of NR-INF-02 and GS using computer-generated
simple randomization sequence. The
unique integer random numbers were then considered (box
containing either placebo or NR-INF-02 or combination)
for allocation of treatment with trial medication generated
at Natural Remedies Pvt. Ltd., Bangalore, India. The trial
subjects and orthopedic consultant were blinded, during the
entire trial period except study investigator (single blind)
who was aware of treatment intervention. The trial procedure
was explained to patients in their respective language
before randomization and enrollment procedure.